Form 8-K - Current report:
SEC Accession No. 0001641172-25-016120
Filing Date
2025-06-23
Accepted
2025-06-23 17:01:47
Documents
12
Period of Report
2025-06-20
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 44561
  Complete submission text file 0001641172-25-016120.txt   212383

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE immx-20250620.xsd EX-101.SCH 3015
3 XBRL LABEL FILE immx-20250620_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE immx-20250620_pre.xml EX-101.PRE 22359
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3814
Mailing Address 10573 W. PICO BLVD. #58 LOS ANGELES CA 90064
Business Address 11400 WEST OLYMPIC BLVD. SUITE 200 LOS ANGELES CA 90064 (888) 958-1084
Immix Biopharma, Inc. (Filer) CIK: 0001873835 (see all company filings)

EIN.: 454869378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41159 | Film No.: 251065698
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)